A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. (Record no. 17016103)

MARC details
000 -LEADER
fixed length control field 02174 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515065104.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200708s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0920-9964
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.schres.2007.03.011
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name George, Mark S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070830
245 00 - TITLE STATEMENT
Title A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Schizophrenia research
Date of publication, distribution, etc. Jul 2007
300 ## - PHYSICAL DESCRIPTION
Extent 42-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain
General subdivision blood supply
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross-Over Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dopamine Agonists
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Image Processing, Computer-Assisted
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Subcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Magnetic Resonance Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Memory, Short-Term
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuropsychological Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxygen
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenanthridines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psychiatric Status Rating Scales
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Dopamine D1
General subdivision agonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Regional Blood Flow
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Molnar, Christine E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grenesko, Emily L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anderson, Berry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mu, Qiwen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Johnson, Kevin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nahas, Ziad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Knable, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fernandes, Prabhavathi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Juncos, Jorge
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Xuemei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nichols, David E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mailman, Richard B
773 0# - HOST ITEM ENTRY
Title Schizophrenia research
Related parts vol. 93
-- no. 1-3
-- p. 42-50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.schres.2007.03.011">https://doi.org/10.1016/j.schres.2007.03.011</a>
Public note Available from publisher's website

No items available.